Wird geladen...

Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology

Introduction: With a gap in a full understanding of the mechanisms by which survival is extended for patients with cancer who are treated with novel biologic and targeted agents, there is the risk that discordant progression-free and overall survival outcomes are observed due to poor clinical trial...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cancer
Hauptverfasser: Hess, Lisa M, Brnabic, Alan, Mason, Oksana, Lee, Pablo, Barker, Scott
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ivyspring International Publisher 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636299/
https://ncbi.nlm.nih.gov/pubmed/31333789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.32205
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!